Treatment of prostatic hyperplasia

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3702

Patent

active

040051943

ABSTRACT:
A series of nonapeptide amides has been found which, upon administration at daily doses of from about 1-500 .mu.g/kg to male warm-blooded animals, cause regression and subsequent elimination of prostatic hyperplasia without causing adverse effects to healthy tissues.

REFERENCES:
the Merck Manual, 12th Ed., 1972, pp. 669-672.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of prostatic hyperplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of prostatic hyperplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of prostatic hyperplasia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1479102

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.